Novel neural pathways of cardiovascular control by α- and γ-MSH

Fundamental and Clinical Pharmacology

Volumn 11, Issue SUPPL. 1, 1997, Pages

  Kunos, G ^a   Li, S J ^a   Varga, K ^a   Archer, P ^a   Kesterson, R A ^a   Cone, R D ^a   Hruby, V J ^a   Sharma, S D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; GAMMA INTERMEDIN; MECAMYLAMINE; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NALOXONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; BRADYCARDIA; BRAIN DEPTH STIMULATION; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; CONTROL SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HYPOTENSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROINJECTION; NERVOUS SYSTEM; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; TACHYCARDIA; VAGUS NERVE DORSAL NUCLEUS;

EID: 0030896395     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00874.x     Document Type: Conference Paper

References (20)

1. Adan RAH, Cone RD, Burbach JPH, Gispen WH (1994) Molec Pharmacol 46: 1182-1190.
2. Callahan MF, Kirby RF, Wolff DW, Strandhoy JW, Lymangrover JR, Johnson AK, Gruber KA (1985) Hypertension 7[Suppl I]:I-145-I-150.
3. De Wildt DJ, Van Der Ven JC, Van Bergen P, De Lang H, Versteeg DHG (1994) Naunyn-Schmiedeberg's Arch Pharmacol 349:50-56.
4. Griffon N, Mignon V, Facchinetti P, Diaz J, Schwartz J-C, Sokoloff P (1994) Biochem Biophys Res Commun 200:1007-1014.
5. Gruber KA, Callahan MF (1989) Am J Physiol 257:R681-R694.
6. Hruby VJ, Lu D, Sharma SD, Castrucci A de L, Kesterson RA, Al-Obeidi FA, Hadley ME, Cone RD (1995) J Med Chem 38:3454-3461.
7. Kunos G, Farsang C, Ramirez-Gonzalez MD (1981) Science 211:82-84.
8. Li S-J, Scanlon MN, Járai Z, Varga K, Gantenberg NS, Lazar-Wesley E, Kunos G (1996) Neuroendocrinology 63:275-283.
9. Li S-J, Varga K, Archer V, Hruby VJ, Sharma S, Kesterson RA, Cone RA, Kunos G (1996) J. Neurosci. In press.
10. Mastrianni JA, Palkovits M, Kunos G (1989) Neuroscience 33:559-566.
11. Mezey E, Kiss JZ, Mueller GP, Eskay R, O'Donohue TL, Palkovits M (1985) Brain Res 328:341-347.
12. Mosqueda-Garcia R, Eskay R, Zamir N, Palkovits M, Kunos G (1986) Endocrinology 118: 1814-1822.
13. Mosqueda-Garcia R, Kunos G (1987) Proc Natl Acad Sci USA 84: 8637-8641.
14. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Molec Endocrinol 8: 1298-1308.
15. O'Donohue TL, Dorsa DM (1982) Peptides 3:353-395.
16. Palkovits M, Eskay RL (1987) Neuropeptides 9:123-137.
17. Petty MA, De Jong W (1982) Eur J Pharmacol 81:449-457.
18. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD (1993) Proc Natl Acad Sci USA 90: 8856-8860.
19. Sim LJ, Joseph SA (1991) J Chem Neuroanat 4: 91-109.
20. Van Giersbergen PLM, Roording P, de Lang H, de Jong W (1989) Brain Res 498: 154-158.